Skip to main content
. 2025 Jan 10;15:1599. doi: 10.1038/s41598-024-84149-x

Table 4.

Antibiotic resistance profiles of selected isolates recovered from Poultry, Equine, Human, and Environmental Samples.

Class Antibiotics* No. of resistant K. pneumoniae isolates (%)
Poultry
n = 6 (%)
Equine
n = 4 (%)
Water
n = 3(%)
Wild Birds
n = 3 (%)
Human
n = 2(%)
Total
n = 18 (%)
Aminoglycosides GEN 4 (66.6) 2 (50.0) 0 (0.0) 2 (66.6) 1 (50) 9 (50.0)
Penicillins AMP 5 (83.8) 4 (100) 2 (66.6) 3 (100) 1 (50) 15 (83.3)
AMC 5 (83.8) 3 (75.0) 0 (0.0) 2 (66.6) 0 (0) 10 (55.5)
Macrolides ERY 3 (50.0) 1 (25.0) 1 (33.3) 2 (66.6) 1 (50) 8 (44.4)
AZM 4 (66.6) 3 (75.0) 1 (33.3) 3 (100) 0 (0) 11 (61.1)
Cephalosporins CTX 4 (66.6) 3 (75.0) 2 (66.6) 2 (66.6) 1 (50) 12 (66.6)
CAZ 3 (50.0) 1 (25.0) 0 (0.0) 1 (25.0) 1 (50) 6 (33.3)
Quinolones NAL 2 (33.3) 1 (25.0) 0 (0.0) 1 (33.3) 1 (50) 5 (27.7)
CIP 2 (33.3) 1 (25.0) 1 (33.3) 0 (0.0) 0 (0) 4 (22.2)
NOR 4 (66.6) 0 (0.0) 1 (33.3) 1 (33.3) 0 (0) 6 (33.3)
Amphenicols CHL 3 (50.0) 1 (25.0) 1 (25.0) 1 (25.0) 0 (0) 6 (33.3)
Tetracycline TET 5 (83.8) 3 (75.0) 1 (33.3) 3 (100) 1 (50) 13 (72.2)
Cephems CT 5 (83.8) 2 (50.0) 1 (33.3) 2 (66.6) 1 (50) 11 (61.1)
Lincosamides CLN 3 (50.0) 2 (50.0) 0 (0.0) 2 (66.6) 1 (50) 8 (44.4)

GEN gentamycin, AMP ampicillin, AMC amoxicillin/clavulanic acid, ERY erythromycin, AZM azithroyn, CTX cefotaxime, CAZ ceftazidime, NAL nalidixic acid, CIP ciprofloxacin, NOR norfloxacin, CHL chloramphenicol, TET tetracycline, CT ceftazidime, CLN clindamycin.